Go to the About Us section
Go to the Courses section
Go to the Research section
Go to the Specialist Services & Consultancy section
Go to the Outreach section
Go to the New Students section
Oxford Brookes spinout company Oxford Expression Technologies has been awarded a grant from Innovate UK to support a partnership with Vaxine Pty Ltd to develop a vaccine for COVID-19.
As a Faculty we are very proud of our diverse research student community, comprising 131 PhD students, 2 MPhil students, 8 masters by research students, 2 PhD by published works and 27 students on our Professional Doctorate in Nursing.
Having pledged to ensure no-one goes hungry during the lockdown restrictions, Oxford City Council has been working with Oxford Brookes University to ensure emergency food supplies also provide a healthy diet.
An international team of scientists led by Oxford Brookes University have discovered a rare genetic variant which helps us to understand the relationship between hearing and speech and language.
Oxford Brookes University has been ranked amongst the 'world’s top universities' in 13 subjects in the latest QS World University Rankings - up from 12 in 2019.
A new study involving the DNA sequencing of mosquitoes in Laos, which spread malaria, dengue, chikungunya and the Zika virus, is uncovering the status of insecticide resistance in these disease carriers.
Prof Sue Vaughan and Dr Jack Sunter at Oxford Brookes with Theresa Manful-Gwira at the University of Ghana organised a networking meeting at the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP). This two day meeting brought together African trypanosomiasis (a neglected tropical disease) experts from West Africa and Europe.
Oxford Brookes Brookes Department of Biological and Medical Sciences alumni, Andrada Tomoni is Lead Author on a research publication that could pave the way to identify new drug targets for the treatment of Cancer, rheumatoid arthritis, autoimmune diseases and more.
Oxford Brookes University has won its first funding award for a project which will market-validate a technology which enables injection-only pharmaceutical drugs to be formulated into pills for oral dosage.